GU Cancers 2020 | Bladder: neoadjuvant immunotherapy & ctDNA
Thanks for your feedback, this will help us improve our content for you!
Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses his research highlights from the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Grivas specifically mentions data from the ABACUS trial (NCT02662309), the PURE-01 trial (NCT02736266) , the BLASST-01 trial (NCT03294304), as well as trials investigating enfortumab vedotin and erdafitinib.
Get great new content delivered to your inboxSign up